Education
About Us
Working with TipRanks
Follow Us
NanoViricides Inc (NNVC)
:NNVC
NNVC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.94 - $2.34
Previous CloseN/A
Volume409.80K
Average Volume (3M)246.81K
Market Cap
$23.63M
Enterprise Value$16.71M
Total Cash (Recent Filing)$2.54M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Nov 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.72
Shares Outstanding16,072,000
10 Day Avg. Volume124,506
30 Day Avg. Volume246,805
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.71
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-87.66
Enterprise Value/Ebitda-1.81
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NanoViricides News
NNVC FAQ
What was NanoViricides Inc’s price range in the past 12 months?
NanoViricides Inc lowest stock price was $0.94 and its highest was $2.34 in the past 12 months.
What is NanoViricides Inc’s market cap?
NanoViricides Inc’s market cap is $23.63M.
When is NanoViricides Inc’s upcoming earnings report date?
NanoViricides Inc’s upcoming earnings report date is Nov 24, 2025 which is in 99 days.
How were NanoViricides Inc’s earnings last quarter?
Currently, no data Available
Is NanoViricides Inc overvalued?
According to Wall Street analysts NanoViricides Inc’s price is currently Overvalued.
Does NanoViricides Inc pay dividends?
NanoViricides Inc does not currently pay dividends.
What is NanoViricides Inc’s EPS estimate?
NanoViricides Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoViricides Inc have?
NanoViricides Inc has 16,072,000 shares outstanding.
What happened to NanoViricides Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NanoViricides Inc?
Currently, no hedge funds are holding shares in NNVC
Company Description
NanoViricides Inc
NanoViricides, Inc. is a development-stage company engaged in creating nanotechnology-based antiviral therapeutics. Its primary focus is on the research and development of drugs to combat viral infections by utilizing a novel platform that deploys nanomaterials to specifically target and neutralize viruses. The company operates in the biotechnology and pharmaceuticals sector, aiming to address unmet medical needs for treatments against viral diseases such as influenza, HIV, and COVID-19.
NanoViricides (NNVC) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Ownership Overview
6.55%
Insiders
4.18% Mutual Funds
1.96% Other Institutional Investors
84.16% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---